Literature DB >> 15760807

Profound morphine tolerance following high-dose methadone therapy.

Kenneth R Eugenio1.   

Abstract

Cross-tolerance among opioid analgesics may be a barrier to effective pain management. Although the exact mechanism is unknown, methadone continues to remain a viable option when other opioids have failed. Limited data are available regarding the impact of high-dose methadone on subsequent opioid analgesics. Conventional opioid doses may be insufficient for an analgesic effect in patients previously treated with methadone. A case of profound morphine tolerance following high-dose methadone therapy is described. The potential role of methadone-induced cross-tolerance is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760807     DOI: 10.1300/j354v18n04_05

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  4 in total

1.  The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study.

Authors:  Sebastiano Mercadante; Patrizia Ferrera; Edoardo Arcuri
Journal:  Support Care Cancer       Date:  2010-09-30       Impact factor: 3.603

2.  Effects of sleep deprivation on sleep homeostasis and restoration during methadone-maintenance: a [31]P MRS brain imaging study.

Authors:  George H Trksak; J Eric Jensen; David T Plante; David M Penetar; Wendy L Tartarini; Melissa A Maywalt; Michael Brendel; Cynthia M Dorsey; Perry F Renshaw; Scott E Lukas
Journal:  Drug Alcohol Depend       Date:  2009-09-22       Impact factor: 4.492

3.  Hepatitis C virus infection influences the S-methadone metabolite plasma concentration.

Authors:  Shiow-Ling Wu; Sheng-Chang Wang; Hsiao-Hui Tsou; Hsiang-Wei Kuo; Ing-Kang Ho; Sheng-Wen Liu; Ya-Ting Hsu; Yao-Sheng Chang; Yu-Li Liu
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

Review 4.  Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.

Authors:  Gustavo A Angarita; Nazli Emadi; Sarah Hodges; Peter T Morgan
Journal:  Addict Sci Clin Pract       Date:  2016-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.